Cumberland PharmaceuticalsCPIX +12.50%32 PS Ratio is 2.39 as of Jun. 27, 2026, which is 66% above its 10-year median of 1.44. GuruFocus rates CPIX with a GF Score™ of 32/100 and a GF Value™ of $2.16 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 953 Drug Manufacturers companies, Cumberland Pharmaceuticals ranks better than 51.42% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Cumberland Pharmaceuticals's share price is $6.75.
Cumberland Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $2.83. Hence, Cumberland Pharmaceuticals's PS Ratio for today is 2.39.
Warning Sign:
Cumberland Pharmaceuticals Inc stock PS Ratio (=2.39) is close to 5-year high of 2.39.
The historical rank and industry rank for Cumberland Pharmaceuticals's PS Ratio or its related term are showing as below:
CPIX'
s PS Ratio Range Over the Past 10 Years
Min: 0.41 Med: 1.44 Max: 3.47
Current: 2.39
During the past 13 years, Cumberland Pharmaceuticals's highest PS Ratio was 3.47. The lowest was 0.41. And the median was 1.44.
CPIX's PS Ratio is ranked better than 51.42% of 953
companies
in the Drug Manufacturers industry
Industry Median: 2.2
vs CPIX: 2.39
Cumberland Pharmaceuticals Inc revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Cumberland Pharmaceuticals was -1.10% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 1.30% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 3.70% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 4.10% per year.
During the past 13 years, Cumberland Pharmaceuticals's highest 3-Year average Revenue per Share Growth Rate was 47.30% per year. The lowest was -7.40% per year. And the median was 3.80% per year.
Back to Basics: PS Ratio
Cumberland Pharmaceuticals (NAS:CPIX) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Cumberland Pharmaceuticals PS Ratio Related Terms
Cumberland Pharmaceuticals PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Cumberland Pharmaceuticals's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cumberland Pharmaceuticals PS Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Cumberland Pharmaceuticals's PS Ratio distribution charts can be found below:
* The bar in red indicates where Cumberland Pharmaceuticals's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Cumberland Pharmaceuticals's Share Price of today is $6.75. Cumberland Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.83.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Cumberland Pharmaceuticals (CPIX) has a PS Ratio of 2.39 as of Jun. 27, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Cumberland Pharmaceuticals and its competitors. This is 66% above median its historical median of 1.44. Over the past decade, Cumberland Pharmaceuticals' PS Ratio has ranged from 0.41 to 3.47. According to the industry distribution chart, Cumberland Pharmaceuticals ranks #463 out of 953 companies in the Drug Manufacturers industry, placing it in the top 48.6%.
Is Cumberland Pharmaceuticals' PS Ratio too high?
Cumberland Pharmaceuticals' current PS Ratio of 2.39 is 66% above median its 10-year median of 1.44. Over the past 10 years, this metric has ranged from a low of 0.41 to a high of 3.47. The Drug Manufacturers industry median PS Ratio is 2.20. Cumberland Pharmaceuticals' value of 2.39 is 8.6% above this industry median. Based on the distribution chart, Cumberland Pharmaceuticals ranks #463 out of 953 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Cumberland Pharmaceuticals has a GF Score™ of 32/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cumberland Pharmaceuticals' PS Ratio compare to CTOR and INCR?
According to the Drug Manufacturers industry distribution chart, Cumberland Pharmaceuticals ranks #463 out of 953 companies for PS Ratio. This puts Cumberland Pharmaceuticals in the upper half of its industry. The industry median PS Ratio is 2.20. Cumberland Pharmaceuticals' value of 2.39 is 8.6% above this benchmark. Historically, Cumberland Pharmaceuticals' own PS Ratio has ranged from 0.41 to 3.47 over the past decade. While the company's 10-year median is 1.44 vs. the industry median of 2.20, Cumberland Pharmaceuticals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Drug Manufacturers company?
The median PS Ratio among Drug Manufacturers companies is 2.20, based on 953 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cumberland Pharmaceuticals's current PS Ratio of 2.39 is 8.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Cumberland Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median PS Ratio is 2.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cumberland Pharmaceuticals's current PS Ratio is 2.39, which is 66% above median its own 10-year median of 1.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cumberland Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Cumberland Pharmaceuticals (CPIX) is currently considered Significantly Overvalued. The stock's GF Value™ is $2.16, compared to a current price of $6.75 — trading 212.5% above its estimated fair value. The current PS Ratio is 2.39, which is 66% above median its 10-year median of 1.44 and 8.6% above the Drug Manufacturers industry median of 2.20. Cumberland Pharmaceuticals' overall GF Score™ is 32/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Cumberland Pharmaceuticals (CPIX), the current PS Ratio is 2.39 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cumberland Pharmaceuticals (CPIX) Overvalued in 2026?
Based on GuruFocus' analysis, Cumberland Pharmaceuticals stock appears to be overvalued.
The current stock price of $6.75 is trading 212.5% above its estimated GF Value™ of $2.16.
GuruFocus considers Cumberland Pharmaceuticals to be Significantly Overvalued.
Key valuation signals for CPIX:
PS Ratio: 2.39 (66% above median its 10-year median of 1.44)
GF Value™: $2.16 vs. price of $6.75 (212.5% above fair value)
Industry Position: 8.6% above the Drug Manufacturers median (#463 of 953)
No single metric tells the full story. See the CPIX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.
32GF Score
Get the complete analysis for CPIX
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CPIX has been successfully added to your 
